Results
257
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
257 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NVDA | US$111.59 | -9.0% | 139.9% | US$2.7t | US$139.32 | PE64.4x | E23.3% | 0.04% | Semiconductors | ||
SRPT | US$146.03 | -1.1% | 35.8% | US$13.8b | US$198.28 | PE816.9x | E39.9% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$149.58 | -0.8% | 46.3% | US$45.5b | US$151.67 | PE69.4x | E29.1% | 2.5% | Diversified Financials | ||
NU | US$12.02 | -6.6% | 52.0% | US$58.5b | US$13.68 | PB8.5x | E27.4% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
PDD | US$127.59 | -4.1% | 41.6% | US$177.2b | US$207.40 | PE16.1x | E21.6% | n/a | Retail | ||
BX | US$141.34 | -1.6% | 33.2% | US$172.5b | US$134.11 | PE54.4x | E26.1% | 2.4% | Diversified Financials | ||
CG | US$47.55 | 2.3% | 34.1% | US$17.1b | US$48.30 | PS7.7x | E23.6% | 2.9% | Diversified Financials | ||
SMCI | US$697.73 | -10.9% | 106.7% | US$40.9b | US$1,033.54 | PE38.9x | E39.0% | n/a | Tech | ||
SYM | US$35.63 | -7.8% | -43.9% | US$22.7b | US$52.25 | PS2.4x | E131.1% | n/a | Capital Goods | ||
OWL | US$19.06 | -3.6% | 55.2% | US$27.6b | US$20.69 | PE139.5x | E88.2% | 3.8% | Diversified Financials | ||
LEGN | US$56.38 | -5.8% | -24.4% | US$10.3b | US$82.63 | PS30x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
RYAN | US$61.72 | 4.4% | 41.3% | US$15.7b | US$60.68 | PE115.5x | E49.2% | 0.7% | Insurance | ||
SPOT | US$330.35 | -0.1% | 119.0% | US$65.0b | US$383.37 | PE131.7x | E29.5% | n/a | Media | ||
ZS | US$181.15 | -5.2% | 11.3% | US$27.4b | US$230.08 | PS13.5x | E50.9% | n/a | Software | ||
NTNX | US$50.01 | -0.3% | 65.5% | US$12.3b | US$74.54 | PS5.9x | E82.7% | n/a | Software | ||
ALNY | US$236.28 | 0.8% | 25.0% | US$29.9b | US$259.31 | PS14.9x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
VRT | US$73.03 | -19.7% | 175.3% | US$29.3b | US$102.80 | PE54.9x | E29.9% | 0.1% | Capital Goods | ||
PTC | US$177.22 | -0.3% | 21.0% | US$21.2b | US$203.05 | PE73.7x | E22.8% | n/a | Software | ||
CHK | US$76.24 | -4.7% | -9.7% | US$10.0b | US$104.65 | PE22.8x | E54.8% | 3.2% | Energy | ||
TER | US$121.34 | -20.3% | 9.1% | US$20.0b | US$145.63 | PE38.2x | E22.3% | 0.4% | Semiconductors | ||
HUBS | US$488.02 | -0.09% | -15.3% | US$25.4b | US$642.31 | PS10.9x | E59.6% | n/a | Software | ||
TEAM | US$178.14 | 1.7% | -1.9% | US$46.4b | US$238.30 | PS11.1x | E45.7% | n/a | Software | ||
ARM | US$141.44 | -17.6% | n/a | US$147.1b | US$127.11 | PE480.9x | E32.5% | n/a | Semiconductors |